Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Accurately identified high-grade prostate cancer through urine testing.

2.

In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.

3.

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

4.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

5.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot